Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes

被引:72
作者
Jung, David [2 ]
Powers, Jon Paul [2 ]
Straus, Suzana K. [1 ]
Hancock, Robert E. W. [2 ]
机构
[1] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada
[2] Univ British Columbia, Dept Microbiol & Immunol, Lower Mall Res Stn 2259, Vancouver, BC V6T 1Z4, Canada
基金
加拿大健康研究院;
关键词
lipopeptide; daptomycin; P-31; NMR; DSC; fluorescence; membrane fusion; model membranes;
D O I
10.1016/j.chemphyslip.2008.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Daptomycin is a cyclic anionic lipopeptide with an antibiotic activity that is completely dependent on the presence of calcium (as Ca2+). In a previous study [Jung et al., 2004. Chem. Biol. 11, 949-957], it was concluded that daptomycin underwent two Ca2+-dependent structural transitions, whereby the first transition was solely dependent on Ca2+, while the second transition was dependent on both Ca2+ and the presence of negatively charged lipids that allowed daptomycin to insert into and perturb bilayer membranes with acidic character. Differences in the interaction of daptomycin with acidic and neutral membranes were further investigated by spectroscopic means. The lack of quenching of intrinsic fluorescence by the water-soluble quencher, KI, confirmed the insertion of the daptomycin Trp residue into the membrane bilayer, while the kynurenine residue was inaccessible even in an aqueous environment. Differential scanning calorimetry (DSC) indicated that the binding of daptomycin to neutral bilayers occurred through a combination of electrostatic and hydrophobic interactions, while the binding of daptomycin to Mayers containing acidic lipids primarily involved electrostatic interactions. The binding of daptomycin to acidic membranes led to the induction of non-lamellar lipid phases and membrane fusion. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 41 条
[1]   NMR structure determination and calcium binding effects of lipopeptide antibiotic daptomycin [J].
Ball, LJ ;
Goult, CM ;
Donarski, JA ;
Micklefield, J ;
Ramesh, V .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2004, 2 (13) :1872-1878
[2]  
BOECK LD, 1990, J ANTIBIOT, V43, P607
[3]   P-31 NMR-STUDIES OF UNSONICATED AQUEOUS DISPERSIONS OF NEUTRAL AND ACIDIC PHOSPHOLIPIDS - EFFECTS OF PHASE-TRANSITIONS, P2H AND DIVALENT-CATIONS ON MOTION IN PHOSPHATE REGION OF POLAR HEADGROUP [J].
CULLIS, PR ;
DEKRUYFF, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 436 (03) :523-540
[4]   LIPID POLYMORPHISM AND THE FUNCTIONAL ROLES OF LIPIDS IN BIOLOGICAL-MEMBRANES [J].
CULLIS, PR ;
DEKRUIJFF, B .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 559 (04) :399-420
[5]  
CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V552, P546, DOI 10.1016/0005-2736(79)90200-1
[6]   ENZYMATIC AND CHEMICAL MODIFICATIONS OF LIPOPEPTIDE ANTIBIOTIC A21978C - THE SYNTHESIS AND EVALUATION OF DAPTOMYCIN (LY146032) [J].
DEBONO, M ;
ABBOTT, BJ ;
MOLLOY, RM ;
FUKUDA, DS ;
HUNT, AH ;
DAUPERT, VM ;
COUNTER, FT ;
OTT, JL ;
CARRELL, CB ;
HOWARD, LC ;
BOECK, LD ;
HAMILL, RL .
JOURNAL OF ANTIBIOTICS, 1988, 41 (08) :1093-1105
[7]   INVITRO AND INVIVO ACTIVITY OF LY 146032, A NEW CYCLIC LIPOPEPTIDE ANTIBIOTIC [J].
ELIOPOULOS, GM ;
WILLEY, S ;
REISZNER, E ;
SPITZER, PG ;
CAPUTO, G ;
MOELLERING, RC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (04) :532-535
[8]   FUSION OF "PHOSPHATIDYLETHANOLAMINE-CONTAINING LIPOSOMES AND MECHANISM OF THE L-ALPHA-HII PHASE-TRANSITION [J].
ELLENS, H ;
BENTZ, J ;
SZOKA, FC .
BIOCHEMISTRY, 1986, 25 (14) :4141-4147
[9]   EFFECT OF PHASE-TRANSITIONS ON THE INTERACTION OF PEPTIDES AND PROTEINS WITH PHOSPHOLIPIDS [J].
EPAND, RM ;
SUREWICZ, WK .
CANADIAN JOURNAL OF BIOCHEMISTRY AND CELL BIOLOGY, 1984, 62 (11) :1167-1173
[10]   INVITRO ACTIVITY OF LY146032 AGAINST STAPHYLOCOCCI, STREPTOCOCCI, AND ENTEROCOCCI [J].
FASS, RJ ;
HELSEL, VL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (05) :781-784